Metropolitan Life Insurance Company (MetLife)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,785
| Closed | -$11.2K | – | 2535 |
|
|
2023
Q1 | $11.2K | Sell |
1,785
-223
| -11% | -$1.39K | ﹤0.01% | 2117 |
|
|
2022
Q4 | $12.2K | Buy |
2,008
+156
| +8% | +$952 | ﹤0.01% | 2217 |
|
|
2022
Q3 | $22.1K | Hold |
1,852
| – | – | ﹤0.01% | 1981 |
|
|
2022
Q2 | $23.4K | Hold |
1,852
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q1 | $20.9K | Sell |
1,852
-5,658
| -75% | -$63.7K | ﹤0.01% | 2073 |
|
|
2021
Q4 | $133K | Hold |
7,510
| – | – | ﹤0.01% | 2299 |
|
|
2021
Q3 | $173K | Buy |
+7,510
| New | +$173K | ﹤0.01% | 2187 |
|
|
2021
Q2 | – | Sell |
-4,693
| Closed | -$146K | – | 2908 |
|
|
2021
Q1 | $146K | Buy |
+4,693
| New | +$146K | ﹤0.01% | 2226 |
|